Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,914 | 846 | 95.5% |
| Education | $566.16 | 5 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $2,528 | 202 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,469 | 124 | $0 (2022) |
| Lundbeck LLC | $1,353 | 127 | $0 (2024) |
| Alkermes, Inc. | $1,263 | 45 | $0 (2024) |
| ITI, Inc. | $1,229 | 51 | $0 (2023) |
| Allergan, Inc. | $765.32 | 92 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $740.53 | 67 | $0 (2024) |
| Corium, LLC | $656.87 | 26 | $0 (2024) |
| ABBVIE INC. | $318.85 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $313.03 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,195 | 92 | Alkermes, Inc. ($543.28) |
| 2023 | $1,538 | 72 | Alkermes, Inc. ($564.79) |
| 2022 | $920.49 | 60 | Sunovion Pharmaceuticals Inc. ($419.76) |
| 2021 | $1,867 | 127 | ITI, Inc. ($565.18) |
| 2020 | $1,260 | 67 | Sunovion Pharmaceuticals Inc. ($413.71) |
| 2019 | $1,683 | 149 | Sunovion Pharmaceuticals Inc. ($526.51) |
| 2018 | $1,562 | 157 | Sunovion Pharmaceuticals Inc. ($483.48) |
| 2017 | $1,453 | 127 | Lundbeck LLC ($330.96) |
All Payment Transactions
851 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: CNS | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: CNS | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: CNS | ||||||
| 11/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.41 | General |
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CNS | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 78 | 227 | $44,775 | $19,690 |
| 2022 | 4 | 65 | 129 | $25,200 | $11,940 |
| 2021 | 4 | 96 | 244 | $47,525 | $21,424 |
| 2020 | 4 | 82 | 203 | $39,675 | $16,336 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 65 | $14,625 | $6,055 | 41.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 46 | $11,500 | $5,344 | 46.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 66 | $9,900 | $4,335 | 43.8% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 20 | 50 | $8,750 | $3,955 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 42 | $9,450 | $4,000 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 21 | $5,250 | $2,920 | 55.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 18 | 42 | $6,300 | $2,835 | 45.0% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 16 | 24 | $4,200 | $2,185 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 81 | $18,225 | $7,531 | 41.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 23 | 86 | $12,900 | $5,822 | 45.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 39 | $9,750 | $4,766 | 48.9% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 27 | 38 | $6,650 | $3,306 | 49.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 77 | $17,325 | $6,280 | 36.2% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 22 | 46 | $8,050 | $4,132 | 51.3% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 19 | 57 | $8,550 | $3,965 | 46.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 23 | $5,750 | $1,959 | 34.1% |
About Dr. Abraham Katz, M.D
Dr. Abraham Katz, M.D is a Psychiatry healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538279807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abraham Katz, M.D has received a total of $12,480 in payments from pharmaceutical and medical device companies, with $2,195 received in 2024. These payments were reported across 851 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($11,914).
As a Medicare-enrolled provider, Katz has provided services to 321 Medicare beneficiaries, totaling 803 services with total Medicare billing of $69,390. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location El Paso, TX
- Active Since 08/30/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1538279807
Products in Payments
- LATUDA (Drug) $2,528
- REXULTI (Drug) $1,317
- CAPLYTA (Drug) $1,229
- VRAYLAR (Drug) $1,044
- TRINTELLIX (Drug) $1,038
- ARISTADA (Drug) $780.84
- Azstarys (Drug) $636.05
- Trintellix (Drug) $621.94
- VYVANSE (Drug) $582.98
- LYBALVI (Drug) $447.07
- FANAPT (Drug) $230.47
- INGREZZA (Drug) $199.85
- Dyanavel XR (Drug) $191.55
- Vyvanse (Drug) $155.74
- JORNAY PM (Drug) $143.40
- QUILLIVANT XR (Drug) $125.93
- MYDAYIS (Drug) $115.07
- INVEGA SUSTENNA (Drug) $98.00
- UZEDY (Drug) $62.55
- BRINTELLIX (Drug) $61.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in El Paso
Martin Guerrero, M.d, M.D
Psychiatry — Payments: $1.9M
Angel Rodriguez-Chevres, M.d, M.D
Psychiatry — Payments: $85,957
Dr. Jesus Jimenez
Psychiatry — Payments: $9,026
Josefina Diaz-Vogt, M.d, M.D
Psychiatry — Payments: $6,746
Dr. Monica Chabra, Do, DO
Psychiatry — Payments: $5,761
Dr. Edgar Gracia, M.d, M.D
Psychiatry — Payments: $5,479